Related Experiment Video
Updated: May 6, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine
Xuelian Wang1, Hannah N Coleman, Uma Nagarajan
1Department of Microbiology and Parasitology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Abstract:
A vaccine adjuvant that can effectively promote cell-mediated immunity is currently not available. Because of the ability of a Candida skin test reagent injection to induce common wart regression, our group is using it as a novel adjuvant in a clinical trial of a peptide-based human papillomavirus therapeutic vaccine. The goal of this current study was to investigate the mechanisms of how Candida enhances the vaccine immune responses. Maturation effects on Langerhans cells, capacity to proliferate T-cells, expression of cytokines and pattern recognition receptors by Langerhans cells, and ability to induce Th1, Th2, and Th17 responses were investigated in healthy subjects. The vaccine, human papillomavirus peptides with Candida, demonstrated partial maturation effects on Langerhans cells indicated by significantly up-regulated CD40 (p=0.00007) and CD80 (p<0.00001) levels, and showed T-cell proliferative capacity (p<0.00001) when presented by Langerhans cells in vitro. Interestingly, the maturation effects were due to the peptides while Candida was responsible for the T-cell proliferation. The cytokine profile (IL-1β, IL-6, IL-8, IL-10, IL-12p40, IL-23Ap19, IFN-γ and TNF-α) of Langerhans cells treated with the vaccine or Candida alone showed that IL-12p40 mRNA was most frequently induced, and IL-12p70 protein was detected in the supernatants. The presence of pattern recognition receptors known to associate with Candida albicans (DC-SIGN, dectin-1, dectin-2, galectin-3, mincle, mannose receptor, Toll-like receptors-1, 2, 4, 6 and 9) were demonstrated in all subjects. On the other hand, the induction of Th1 response demonstrated by IFN-γ secretion by CD4 cells stimulated with the vaccine or Candida pulsed Langerhans cells was demonstrated only in one subject. In summary, the Langerhans cell maturation effects of the vaccine were due to the peptides while the T-cell proliferative capacity was derived from Candida, and the most frequently induced cytokine was IL-12.
Insights
Candida enhances human papillomavirus (HPV) vaccine immune responses by promoting Langerhans cell maturation and T-cell proliferation. This study investigated how Candida acts as an adjuvant to boost vaccine efficacy for HPV therapeutic vaccines.
Area of Science:
- Immunology
- Vaccinology
- Dermatology
Background:
- Effective cell-mediated immunity induction by vaccine adjuvants remains a challenge.
- Candida skin test reagent shows potential in inducing regression of common warts.
- A novel therapeutic vaccine for human papillomavirus (HPV) utilizes a peptide-based approach combined with Candida as a potential adjuvant.
Purpose of the Study:
- To elucidate the mechanisms by which Candida enhances immune responses to a peptide-based HPV therapeutic vaccine.
- To investigate the effects of the vaccine and Candida on Langerhans cells, T-cell proliferation, cytokine expression, and pattern recognition receptors.
- To assess the induction of Th1, Th2, and Th17 responses in healthy subjects.
Main Methods:
- Analysis of Langerhans cell maturation markers (CD40, CD80) following treatment with the HPV vaccine and Candida.
- Assessment of T-cell proliferation capacity when presented by Langerhans cells in vitro.
- Quantification of cytokine profiles (mRNA and protein) and evaluation of pattern recognition receptor expression in Langerhans cells.
Main Results:
- The HPV vaccine peptides induced partial maturation of Langerhans cells, evidenced by increased CD40 and CD80 expression.
- Candida was identified as the primary driver of T-cell proliferation, while peptides mediated Langerhans cell maturation.
- Interleukin-12p40 (IL-12p40) mRNA was frequently induced, and IL-12p70 protein was detected; Th1 response induction was limited.
Conclusions:
- The study delineates the distinct roles of HPV peptides and Candida in modulating Langerhans cell and T-cell responses.
- Candida acts as a potent inducer of T-cell proliferation, a crucial component for cell-mediated immunity.
- The findings support the potential of Candida as a novel adjuvant for enhancing the efficacy of peptide-based therapeutic vaccines, particularly for HPV.
More Related Videos
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018